Comparative Pharmacology
Head-to-head clinical analysis: EFIDAC 24 PSEUDOEPHEDRINE HYDROCHLORIDE BROMPHENIRAMINE MALEATE versus WYAMINE SULFATE.
Peer-Reviewed Evidence
Head-to-head clinical analysis: EFIDAC 24 PSEUDOEPHEDRINE HYDROCHLORIDE BROMPHENIRAMINE MALEATE versus WYAMINE SULFATE.
EFIDAC 24 PSEUDOEPHEDRINE HYDROCHLORIDE/BROMPHENIRAMINE MALEATE vs WYAMINE SULFATE
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Pseudoephedrine is a sympathomimetic amine that acts as a decongestant by stimulating alpha-adrenergic receptors in the respiratory tract mucosa, causing vasoconstriction and reducing nasal congestion. Brompheniramine is a first-generation antihistamine that competitively antagonizes histamine at H1 receptors, alleviating symptoms of allergic rhinitis.
Wyamine sulfate (mephentermine sulfate) is a sympathomimetic amine that acts primarily by releasing norepinephrine from presynaptic nerve terminals, with direct alpha- and beta-adrenergic receptor agonist activity. It causes vasoconstriction and positive inotropic effects, increasing cardiac output and blood pressure.
1 tablet orally every 12 hours. Each tablet contains pseudoephedrine HCl 120 mg and brompheniramine maleate 4 mg.
Intramuscular injection: 15-30 mg as a single dose; may repeat in 10-15 minutes if needed. Maximum total dose: 60 mg.
None Documented
None Documented
Pseudoephedrine: 4-6 hours (range 3-16 hours); prolonged in alkaline urine or renal impairment. Brompheniramine: 11-27 hours (mean ~24 hours); prolonged in elderly or hepatic impairment.
Terminal elimination half-life is 6-8 hours in adults with normal renal function (CrCl >90 mL/min).
Pseudoephedrine: ~70-90% excreted unchanged in urine, with the remainder as inactive metabolites; renal elimination depends on urine pH (acidic urine increases excretion). Brompheniramine: ~75% metabolized in liver; renal excretion of metabolites and <5% unchanged; biliary/fecal elimination is minor.
Primarily renal; 90% excreted unchanged in urine within 24 hours. Minimal biliary/fecal elimination (<5%).
Category A/B
Category C
Sympathomimetic
Sympathomimetic